Found 7 matching trials
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
PHASE1Background:
Blood, tissue, and tumor cells contain genes. Genes are made u...
Location
National Institutes of Health Clinical Center
Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia
PHASE2This phase II trial is studying the side effects and how well decitabine wo...
Location
UCSF Medical Center-Mount Zion
Geriatric Assessment & Genetic Profiling to Personalize Therapy in Older Adults With Acute Myeloid Leukemia
PHASE2Acute myeloid leukemia (AML) is among the most common hematologic malignanc...
Location
University of Nebraska Medical Center
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
PHASE2This phase II trial studies the side effects and how well fludarabine phosp...
Location
M D Anderson Cancer Center
Ruxolitinib Phosphate and Decitabine in Treating Patients With Relapsed or Refractory or Post Myeloproliferative Acute Myeloid Leukemia
PHASE1This phase I/II trial studies the side effects and best dose of ruxolitinib...
Location
M D Anderson Cancer Center
Decitabine With GCLAM for Adults With Newly Diagnosed, Relapsed, or Refractory AML or High-Risk MDS
PHASE1This phase I/II trial studies the side effects and best dose of decitabine ...
Location
Fred Hutch/University of Washington Cancer Consortium
Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer
PHASE1This phase I/II trial studies the side effects and best dose of decitabine ...
Location
Roswell Park Cancer Institute